APPENDICES - NIHR Health Technology Assessment Programme
APPENDICES - NIHR Health Technology Assessment Programme
APPENDICES - NIHR Health Technology Assessment Programme
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
DOI: 10.3310/hta14370 <strong>Health</strong> <strong>Technology</strong> <strong>Assessment</strong> 2010; Vol. 14: No. 37<br />
40. Christensen E, Skogvoll E, Viset T, Warloe<br />
T, Sundstrom S. Photodynamic therapy with<br />
5-aminolaevulinic acid, dimethylsulfoxide and<br />
curettage in basal cell carcinoma: a 6-year clinical<br />
and histological follow-up. J Eur Acad Dermatol<br />
Venereol 2009;23:58–66.<br />
41. Clark C, Bryden A, Dawe R, Moseley H, Ferguson<br />
J, Ibbotson SH. Topical 5-aminolaevulinic acid<br />
photodynamic therapy for cutaneous lesions:<br />
outcome and comparison of light sources.<br />
Photodermatol Photoimmunol Photomed 2003;19:<br />
134–41.<br />
42. de Haas ERM, de Vijlder HC, Sterenborg HJCM,<br />
Neumann HAM, Robinson DJ. Fractionated<br />
aminolevulinic acid-photodynamic therapy provides<br />
additional evidence for the use of PDT for nonmelanoma<br />
skin cancer. J Eur Acad Dermatol Venereol<br />
2008;22:426–30.<br />
43. Devirgiliis V, Panasiti V, Curzio M, Gobbi S, Rossi<br />
M, Roberti V, et al. Complete remission of nodular<br />
basal cell carcinoma after combined treatment with<br />
photodynamic therapy and imiquimod 5% cream.<br />
Dermatol Online J 2008;14.<br />
44. Dijkstra AT, Majoie IM, van Dongen JW, van<br />
Weelden H, van Vloten WA. Photodynamic therapy<br />
with violet light and topical 6-aminolaevulinic<br />
acid in the treatment of actinic keratosis, Bowen’s<br />
disease and basal cell carcinoma. J Eur Acad Dermatol<br />
Venereol 2001;15:550–4.<br />
45. Domaniecki J, Stanowski E, Graczyk A, Kalczak M,<br />
Struzyna J, Kwasny M, et al. Photodynamic method<br />
used for the treatment of malignant melanoma<br />
and Merkel cell carcinoma. SPIE Proceedings Series<br />
1997;3188:122–7.<br />
46. Dougherty TJ, Cooper MT, Mang TS. Cutaneous<br />
phototoxic occurrences in patients receiving<br />
Photofrin. Lasers Surg Med 1990;10:485–8.<br />
47. Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt<br />
KR, Boyle D, Mittleman A. Photoradiation therapy<br />
for the treatment of malignant tumors. Cancer Res<br />
1978;38:2628–35.<br />
48. Edstrom DW, Hedblad MA. Long-term follow-up of<br />
photodynamic therapy for mycosis fungoides. Acta<br />
Dermatol Venereol 2008;88:288–90.<br />
49. Edstrom DW, Porwit A, Ros AM. Photodynamic<br />
therapy with topical 5-aminolevulinic acid for<br />
mycosis fungoides: clinical and histological<br />
response. Acta Dermatol Venereol 2001;81:184–8.<br />
50. Eibenschutz L, Marenda S, Mariani G, Ferrari A,<br />
Silipo V, Catricala C. MAL-PDT for the treatment<br />
of large basal cell carcinomas. J Invest Dermatol<br />
2006;126:S16.<br />
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.<br />
51. El-Far M, Setate A, El-Maddawy M. First initial<br />
clinical application of photodynamic therapy (PDT)<br />
in Egypt: two case reports. Laser Life Sci 1998;8:<br />
27–35.<br />
52. Elliott S, Keller G, Razum N, Parks J, White R,<br />
Seiler A. Photodynamic therapy of nonmelanoma<br />
skin-cancer using a ktp-pumped dye-laser. SPIE<br />
Proceedings Series 1993;1881:2–9.<br />
53. Elliott SL. The incidence and etiology of<br />
nonmelanoma skin cancer and selected<br />
management with photodynamic therapy. Laser<br />
Nursing 1992;6:83–91.<br />
54. Evtushenko VA, Soldatov AN, Vusik MV, Reimer<br />
IV. Treatment of basal-cellular skin cancer and<br />
heavy concomitant diseases by a photodynamic<br />
therapeutic method with a dye laser LITT-PDT.<br />
SPIE Proceedings Series 2007;6938:32.<br />
55. Fai D. MAL-PDT for the treatment of multiple<br />
basal cell carcinomas in a patient with Gorlin-Goltz<br />
syndrome. J Invest Dermatol 2006;126:S34-S.<br />
56. Fijan S, Honigsmann H, Ortel B. Photodynamic<br />
therapy of epithelial skin tumours using deltaaminolaevulinic<br />
acid and desferrioxamine. Br J<br />
Dermatol 1995;133:282–8.<br />
57. Filonenko E, Sokolov V, Sukhin D. Fluorescent<br />
diagnostics and photodynamic therapy of malignant<br />
cutaneous tumours. Photodynamic Therapy<br />
and Photodiagnosis in Clinical Practice, Brixen/<br />
Bressanone, 7–11 October, 2008. Poster session –<br />
SPO5.<br />
58. Fink-Puches R, Soyer HP, Hofer A, Kerl H, Wolf P.<br />
Long-term follow-up and histological changes of<br />
superficial nonmelanoma skin cancers treated with<br />
topical delta-aminolevulinic acid photodynamic<br />
therapy. Arch Dermatol 1998;134:821–6.<br />
59. Fink-Puches R, Wolf P, Kerl H. Photodynamic<br />
therapy of superficial basal cell carcinoma by<br />
instillation of aminolevulinic acid and irradiation<br />
with visible light. Arch Dermatol 1997;133:1494–5.<br />
60. Gaal M, Gyulai R, Baltas E, Kui R, Olah J, Kemeny<br />
L. [Photodynamic therapy in dermatooncology.] Orv<br />
Hetil 2007;148:2227–33.<br />
61. Gayl Schweitzer V. Photofrin-mediated<br />
photodynamic therapy for treatment of aggressive<br />
head and neck nonmelanomatous skin tumors in<br />
elderly patients. Laryngoscope 2001;111:1091–8.<br />
62. Ghaffar SA, Clements SE, Lear JT. Epidermoid<br />
cysts mimicking recurrence of superficial basal cell<br />
carcinoma following photodynamic therapy. Clin<br />
Exp Dermatol 2007;32:223–4.<br />
141